0000000000220043

AUTHOR

Lio E

showing 16 related works from this author

Methionine synthase polymorphism A2756G and its association with thromboembolic disease

2007

researchProduct

Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase MTHFR A1298C gene polymorphism in subjects affected by thromboembolic d…

2007

researchProduct

C677T and A1298C polymorphism of the methylentetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis

2007

researchProduct

Factor V Leiden, Prothrombin G20210A mutations are risk factors for deep vein thrombosis

2007

researchProduct

Low Fetuin-A plasma levels are associated with the presence of carotid plaques in patients on dialysis.

2006

researchProduct

Association between angiotensin I - converting enzyme gene insertion/deletion polymorphism and thromboembolic disease.

2007

Thromboembolic disease
researchProduct

Vitamin E and vitamin A plasma levels in patients with Mild Cognitive Impairent (MCI)

2007

researchProduct

Homocysteine and MTHFR gene polimorphysms in patients with venous tromboembolic disease

2006

researchProduct

Apo E polymorphism as risk factor for cardiovascular diseases in Sicilian subjects.

2007

researchProduct

Prevalence and association of the Factor V Leiden and Prothrombin G20210A in healthy subjects and patients with venous tromboembolism

2006

researchProduct

Effect of MTHFR polymorphism on homocysteine level after methionine loading in thromboembolic patients.

2005

researchProduct

Mutations in Factor V Leiden (G1691A) and Prothrombin (G2021A) genes are important risk factors for venous thromboembolism

2007

researchProduct

Apoliprotein E gene polymorphism in subjects affected by cardiovascular disease in Sicilian populations

2006

researchProduct

Methionine loading test and genetic risk factors in subjects affected by thromboembolic disease

2005

researchProduct

Hyperhomocysteinemia and methylenetetrahydrofolare reductase 677C→T and 1298A→C mutations in patients with venous thromboembolic disease

2007

researchProduct

The risk of cardiovascular events is reduced by lowering hyperhomocysteinemia short term B vitamins therapy

2007

researchProduct